Marshall Wace
HIMS icon

Marshall Wace’s Hims & Hers Health HIMS Stock Holding History

Marshall Wace’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15M Buy
724,227
+717,929
+11,399% +$17M 0.02% 803
2025
Q4 		$204K Buy
+6,298
New +$270K ﹤0.01% 2589
2025
Q3 		– Sell
-105,450
Closed -$5.26M – 3083
2025
Q2 		$5.26M Sell
105,450
-156,422
-60% -$7.07M 0.01% 1114
2025
Q1 		$7.74M Buy
261,872
+218,844
+509% +$8.13M 0.01% 870
2024
Q4 		$1.04M Sell
43,028
-1,572,345
-97% -$39M ﹤0.01% 1714
2024
Q3 		$29.8M Sell
1,615,373
-590,581
-27% -$10.6M 0.04% 393
2024
Q2 		$44.5M Sell
2,205,954
-3,434,276
-61% -$57.1M 0.06% 287
2024
Q1 		$87.3M Buy
5,640,230
+370,747
+7% +$4.18M 0.13% 149
2023
Q4 		$46.9M Sell
5,269,483
-906,207
-15% -$6.7M 0.08% 248
2023
Q3 		$38.8M Buy
6,175,690
+299,823
+5% +$2.23M 0.08% 256
2023
Q2 		$55.2M Buy
5,875,867
+1,904,930
+48% +$18.9M 0.11% 198
2023
Q1 		$39.4M Sell
3,970,937
-516,101
-12% -$4.52M 0.08% 265
2022
Q4 		$28.8M Buy
4,487,038
+2,236,609
+99% +$12.7M 0.06% 343
2022
Q3 		$12.6M Buy
2,250,429
+104,736
+5% +$631K 0.03% 715
2022
Q2 		$9.72M Buy
2,145,693
+1,085,736
+102% +$4.63M 0.02% 896
2022
Q1 		$5.65M Buy
1,059,957
+1,050,743
+11,404% +$5.2M 0.01% 1270
2021
Q4 		$60K Sell
9,214
-46,528
-83% -$336K ﹤0.01% 3521
2021
Q3 		$421K Buy
+55,742
New +$472K ﹤0.01% 2477
2021
Q1 		– Sell
-186,615
Closed -$2.73M – 2632
2020
Q4 		$2.73M Sell
186,615
-63,381
-25% -$704K 0.01% 813
2020
Q3 		$2.94M Hold
249,996
– – 0.02% 698
2020
Q2 		$2.54M Hold
249,996
– – 0.02% 703
2020
Q1 		$2.5M Hold
249,996
– – 0.03% 556
2019
Q4 		$2.48M Buy
+249,996
New +$2.47M 0.02% 750

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DE
Defiance ETFs New York $6.98B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Marshall Wace's HIMS Position: Q1 2026 in Review

Marshall Wace increased its Hims & Hers Health (HIMS) stake by 11,399% in Q1 2026, buying an estimated $17M and bringing the position to 724,227 shares worth $15M. The position accounts for 0.02% of the portfolio, ranked #803.

Marshall Wace first reported a position in HIMS in Q4 2019 and has held it in 23 quarters since. The position peaked at $87.3M in Q1 2024. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Marshall Wace held 724,227 shares of Hims & Hers Health worth $15M as of Q1 2026.
  • Marshall Wace bought 717,929 Hims & Hers Health shares in Q1 2026, an estimated $17M.
  • Hims & Hers Health made up 0.02% of Marshall Wace's portfolio in Q1 2026, its #803 holding.
  • Marshall Wace first reported a position in Hims & Hers Health in Q4 2019 and has held it in 23 quarters since.
  • Marshall Wace's Hims & Hers Health position peaked at $87.3M in Q1 2024.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.